Glycopyrrolate and Visual impairment - a phase IV clinical study of FDA data
Summary:
Visual impairment is reported as a side effect among people who take Glycopyrrolate (glycopyrrolate), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Simvastatin, and have Multiple myeloma.
The phase IV clinical study analyzes which people have Visual impairment when taking Glycopyrrolate. It is created by eHealthMe based on reports of 5,510 people who have side effects when taking Glycopyrrolate from the FDA, and is updated regularly.
What is Glycopyrrolate?
Glycopyrrolate has active ingredients of glycopyrrolate. It is often used in hyperhidrosis. eHealthMe is studying from 5,599 Glycopyrrolate users. Check the latest studies of Glycopyrrolate.
What is Visual impairment?
Visual impairment is found to be associated with 2,249 drugs and 2,336 conditions by eHealthMe. Check the latest studies of Visual impairment.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
5,510 people reported to have side effects when taking Glycopyrrolate.
Among them, 43 people (0.78%) have Visual impairment.

Among these 43 people:
How long have people been on Glycopyrrolate when they have Visual impairment? *
- < 1 month: 0.0 %
- 1 - 6 months: 66.67 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 33.33 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Visual impairment when taking Glycopyrrolate? *
- female: 54.29 %
- male: 45.71 %
What is the age of people who have Visual impairment when taking Glycopyrrolate? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 7.69 %
- 40-49: 0.0 %
- 50-59: 50.0 %
- 60+: 42.31 %
What are other drugs people take besides Glycopyrrolate? *
- Simvastatin: 17 people, 39.53%
- Digoxin: 14 people, 32.56%
- Lasix: 12 people, 27.91%
- Cardizem: 11 people, 25.58%
- Atrovent: 11 people, 25.58%
- Hydrocortisone: 11 people, 25.58%
- Fentanyl: 11 people, 25.58%
- Roxicet: 11 people, 25.58%
- Aredia: 10 people, 23.26%
- Plavix: 10 people, 23.26%
What are other side effects people have besides Visual impairment? *
- Weight Decreased: 18 people, 41.86%
- Cataract (clouding of the lens inside the eye): 18 people, 41.86%
- Cardiac Disorder: 15 people, 34.88%
- Hypotension (abnormally low blood pressure): 15 people, 34.88%
- Heart Disease: 14 people, 32.56%
- Thrombocytopenia (decrease of platelets in blood): 13 people, 30.23%
- Pain: 12 people, 27.91%
- Dyspnea (difficult or laboured breathing): 12 people, 27.91%
- Pleural Effusion (water on the lungs): 12 people, 27.91%
- Pulmonary Oedema (fluid accumulation in the lungs): 12 people, 27.91%
What are the existing conditions these people have? *
- Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 10 people, 23.26%
- Multiple Myeloma (cancer of the plasma cells): 10 people, 23.26%
- High Blood Cholesterol: 8 people, 18.60%
- Asthma: 6 people, 13.95%
- Psoriasis (immune-mediated disease that affects the skin): 6 people, 13.95%
- Hypercalcaemia (elevated calcium (ca+) level in the blood): 5 people, 11.63%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 6.98%
- Thrombosis (formation of a blood clot inside a blood vessel): 3 people, 6.98%
- Delusion (a false belief or opinion): 2 people, 4.65%
- Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 4.65%
* Approximation only. Some reports may have incomplete information.
Do you take Glycopyrrolate and have Visual impairment?
- Check whether Visual impairment is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Glycopyrrolate:
- Glycopyrrolate (5,599 reports)
Visual impairment treatments and more:
- Visual impairment (128,338 reports)
How severe was Visual impairment and when was it recovered:
Expand to all the drugs that have ingredients of glycopyrrolate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Glycopyrrolate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Visual impairment:
- Visual impairment (2,249 drugs)
Browse all the conditions that are associated with Visual impairment:
- Visual impairment (2,336 conditions)
Related publications that referenced our studies
- D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .
- D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on glycopyrrolate (the active ingredients of Glycopyrrolate) and Glycopyrrolate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Tardive Dyskinesia and Joint Stiffness - 2 seconds ago
- Could Botox cause Fever? - 3 seconds ago
- Could Mevacor cause Nervous System Disorder? - 9 seconds ago
- Could Glucophage cause Ocular Hyperaemia? - 15 seconds ago
- Drug interactions of Restasis and Benicar - 18 seconds ago
- Drug interactions of Vistaril and Stelazine - 27 seconds ago
- Could Glucophage Xr cause Nosebleed? - 32 seconds ago
- Restless Leg Syndrome and High Blood Pressure - 33 seconds ago
- Drug interactions of Baclofen and Fluoxetine - 35 seconds ago
- Could Glucagon cause Thrombocytopenia? - 35 seconds ago